Itau Unibanco Holding S.A.’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $35.6K | Sell |
647
-11
| -2% | -$605 | ﹤0.01% | 291 |
|
|
2025
Q1 | $47K | Sell |
658
-5
| -0.8% | -$357 | ﹤0.01% | 240 |
|
|
2024
Q4 | $43.6K | Buy |
663
+90
| +16% | +$5.92K | ﹤0.01% | 257 |
|
|
2024
Q3 | $40.3K | Buy |
573
+4
| +0.7% | +$281 | ﹤0.01% | 196 |
|
|
2024
Q2 | $46.8K | Buy |
+569
| New | +$46.8K | ﹤0.01% | 172 |
|
|
2024
Q1 | – | Sell |
-667
| Closed | -$64.3K | – | 146 |
|
|
2023
Q4 | $64.3K | Buy |
667
+79
| +13% | +$7.62K | ﹤0.01% | 205 |
|
|
2023
Q3 | $52K | Sell |
588
-3
| -0.5% | -$265 | ﹤0.01% | 261 |
|
|
2023
Q2 | $51.2K | Sell |
591
-2
| -0.3% | -$173 | ﹤0.01% | 323 |
|
|
2023
Q1 | $57.7K | Sell |
593
-2
| -0.3% | -$194 | ﹤0.01% | 334 |
|
|
2022
Q4 | $61.6K | Buy |
595
+23
| +4% | +$2.38K | ﹤0.01% | 327 |
|
|
2022
Q3 | $48K | Sell |
572
-297
| -34% | -$24.9K | ﹤0.01% | 390 |
|
|
2022
Q2 | $72K | Hold |
869
| – | – | ﹤0.01% | 307 |
|
|
2022
Q1 | $67K | Hold |
869
| – | – | ﹤0.01% | 266 |
|
|
2021
Q4 | $77K | Buy |
869
+236
| +37% | +$20.9K | ﹤0.01% | 232 |
|
|
2021
Q3 | $49K | Buy |
633
+225
| +55% | +$17.4K | ﹤0.01% | 261 |
|
|
2021
Q2 | $34K | Buy |
+408
| New | +$34K | ﹤0.01% | 242 |
|